The effect of CYP2C19 gene polymorphisms on the pharmacokinetics and pharmacodynamics of prasugrel 5-mg, prasugrel 10-mg and clopidogrel 75-mg in patients with coronary artery disease

Thomas O. Bergmeijer, Paul A. Gurbel, Jurriën M. ten Berg et al.|Thrombosis and Haemostasis|2014

Cited by 32